Chips Act accelerates semiconductor investments across europe

Europe is deploying the European Chips Act to mobilise tens of billions of euros for new semiconductor plants, design centres and pilot lines, as it tries to rebuild capacity without losing ground in global chip production. Smaller states such as Malta are using low operating costs and agile regulation to secure a strategic role in the emerging ecosystem.

Regulatory expectations for adaptive artificial intelligence in medical devices

Regulators in the US, EU, and UK are defining expectations for adaptive artificial intelligence in medical technologies, with emphasis on change control, post market surveillance, and cybersecurity. Companies are being pushed to design predictable update mechanisms and continuous monitoring around learning systems.